Research

New Gene-Editing Tech Holds Promise for Treating Complex Genetic Diseases

Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA.

Accolades

Virus Slayer Awarded ‘Genius Grant’ by MacArthur Foundation

The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.

Announcements

In Memoriam: Emin Ulug

Emin Ulug, retired Molecular Biosciences Associate Professor of Instruction passed away on September 12 after a long illness.

Emin Ulug and Hank Bose

Research

Re-engineered Antibodies Kill Bacteria Directly

These antibodies use a clever trick to slip deep into a bacteria’s outer membrane, where they can do real damage.

A microscope image of a bacterium that has been treated with a re-engineered antibody that disrupts the outer membrane and causing the bacterium to spill its contents.

Accolades

Three UT Austin Faculty Members Selected to the American Association for the Advancement of Science

Ken Keiler studies basic molecular biology with the aim of developing new antibiotics.

Research

Research Identifies Key Antibodies for Development of Broadly Protective Norovirus Vaccine

Discovery brings us one step closer to vaccine and treatment for prevalent virus.

Announcements

UT Vaccine Scientist Will Be Inducted Into National Inventors Hall of Fame

McLellan, who will be inducted in Washington, D.C. on May 8, is among the youngest new inductees in hall of fame history.

Research

Newly Discovered Antimicrobial Could Prevent or Treat Cholera

Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection.

UT News

Newly Discovered Antibody Protects Against All COVID-19 Variants

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as similar coronaviruses.

Research

AI Opens Door to Safe, Effective New Antibiotics to Combat Resistant Bacteria

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.